Serial Number
98773003
Owner
EntityRisk, Inc.Attorney
Tracy WellsFirst Use Date
May 5, 2024
Filing Date
Sep 26, 2024
COMMERCIALML Trademark
Serial Number: 98773003
Trademark Classes
Owner Contact Info
Legal Representation
Correspondence Address
Tracy Wells Wells Law
9171 Wilshire BLVD STE 500
Beverly Hills, CA 90210
United States
Trademark Details
Filing Date
September 26, 2024
Registration Date
Not Registered
First Use Anywhere
May 5, 2024
First Use in Commerce
May 5, 2024
Goods & Services
Design, development, and implementation of software for predicting asset values, determining pricing, evidence-generation, contracting by utilizing a pricing and generalized value module and commercial due diligence module, building financial recommendations based on clinical evidence of benefit and risk, expediting value assessment, and providing a qualitative evidence based financial approach to support decisions about pricing, evidence generation and contracting; Providing an interactive website featuring technology that allows users to enter, access, and synthesize information and generate reports for use in consulting with executives and businesses; Software as a service (SAAS) featuring software for predicting business asset values, determining pricing, evidence generation, and contracting by utilizing a pricing and generalized value module and commercial due diligence module.
Computer software platforms, downloadable, for predicting asset values, determining pricing, evidence-generation, and contracting by utilizing a pricing and generalized value module and commercial due diligence module; Computer software platforms, downloadable, for use in building financial recommendations based on clinical evidence of benefit and risk, expediting value assessment, and providing a qualitative evidence based financial approach to support decisions about pricing, evidence generation and contracting; Computer software platforms, downloadable, for use in forecasting and quantifying the commercial revenue opportunity and downside risks under all efficacy and marketplace competition scenarios to support go-to-market pricing and value-based care strategies